Friday April 26, 2024 | Last Update: April 26, 2024 EDT
KaloBios Pharmaceuticals, Inc. has announced in a press release that it will be acquiring a benznidazole program from Savant Neglected Diseases, LLC, a privately-held specialty pharmaceutical company. The program is used for the treatment of Chagas Disease.
Read more >>
Just In
Most Read
1
2
3
4
5